News

Capital Brief on MSN4d
Lumos Diagnostics shares soar 155% after $487m deal
Lumos Diagnostics' shares more than doubled in value in afternoon trade after the biotech announced a US$317 million ($487 ...
Investornewsbreaks Zacks Research Releases Updated Report As Soligenix Inc. (NASDAQ: SNGX) Eyes Upcoming 'Key Catalysts'
Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a July 10 Zacks Small-Cap Research repo ...
Moderna: Ready For The Redemption Arc
Moderna stock has faced heavy pressure from negative headlines, regulatory setbacks and political uncertainty. See why I ...
Zacks Small Cap Research on MSN5d
NNVC: NanoViricides Set to Initiate Phase 2 Trial in MPox
NNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum ...
Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq’s Stockholders’ Equity Standard
Detailed price information for Salarius Pharmaceuticals Inc (SLRX-Q) from The Globe and Mail including charting and trades.